AJP - Endocrinology and Metabolism, Vol 264, Issue 2 E294-E300, Copyright © 1993 by American Physiological Society

ARTICLES

Characterization of a common VIP-PACAP receptor in human small intestinal epithelium

R. Salomon, A. Couvineau, C. Rouyer-Fessard, T. Voisin, D. Lavallee, A. Blais, D. Darmoul and M. Laburthe
Institut National de la Sante et de la Recherche Medicale, Unite 239, Faculte de Medecine X. Bichat, Paris, France.

Vasoactive intestinal peptide (VIP) receptors were characterized in epithelial plasma membranes from human small intestine. Native VIP inhibited the binding of 125I-labeled VIP to jejunal membranes, and Scatchard analysis of these data was consistent with the existence of one class of receptor with a dissociation constant of 42 pM and a maximal binding of 256 fmol/mg membrane protein. VIP stimulated adenylyl cyclase activity in human jejunal membranes in the 0.01 nM-1 microM range [half-maximal effective dose = 0.7 nM]. Coupling of VIP receptors with a Gs protein was further assessed by the ability of GTP (10(-8) to 10(-3) M) to inhibit 125I-VIP binding to membranes. 125I-VIP binding was seven to eight times higher in villus cells than in crypt cells. Finally, 125I-VIP binding was detectable throughout the small and large intestines with the highest binding in jejunum. Among the natural peptides structurally related to VIP, some inhibited 125I-VIP binding with the following order of potency: VIP = pituitary adenylate cyclase-activating peptide (PACAP)-27 = PACAP-38 > helodermin >> peptide histidine methionineamide = human growth hormone-releasing factor > secretin. The same order of potency of peptides for inhibiting 125I-VIP or 125I-labeled PACAP was observed, supporting that the two tracers bound to a common VIP-PACAP receptor site. This order of potency was also observed for the stimulation of adenylyl cyclase activity by these peptides. 125I-VIP was cross-linked to membranes using disuccinimidyl suberate. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis, one single band of 70,000 mol wt was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. Du, A. Couvineau, C. Rouyer-Fessard, P. Nicole, and M. Laburthe Human VPAC1 Receptor Selectivity Filter. IDENTIFICATION OF A CRITICAL DOMAIN FOR RESTRICTING SECRETIN BINDING J. Biol. Chem., September 27, 2002; 277(40): 37016 - 37022. [Abstract] [Full Text] [PDF]

				D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324. [Abstract] [Full Text] [PDF]

				M. Fujimiya, H. Yamamoto, and A. Kuwahara Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G731 - G739. [Abstract] [Full Text] [PDF]

				K. A. Barada, N. E. Saade, S. F. Atweh, and C. F. Nassar Neural mediation of vasoactive intestinal polypeptide inhibitory effect on jejunal alanine absorption Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G822 - G828. [Abstract] [Full Text] [PDF]